Showing results (351-360 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|May 19, 2022
Risperidone-induced neuroleptic malignant syndrome: a case reportLing Deng, Zhi-Xin Qiu, Mao-Yun WangTherapeutic Advances in Psychopharmacology|May 31, 2022
Treatment strategies for clozapine-induced hypotension: a systematic reviewTimothy David Tanzer, Thomas Brouard, Samuel Dal Pra, et al.Therapeutic Advances in Psychopharmacology|September 14, 2019
Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitatorsRhona Eveleigh, Anne Speckens, Chris van Weel, et al.Therapeutic Advances in Psychopharmacology|October 23, 2018
Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspectiveStephen M LawrieTherapeutic Advances in Psychopharmacology|September 7, 2019
Trim the fat: the role of omega-3 fatty acids in psychopharmacologyMadeeha Nasir, Michael H BlochTherapeutic Advances in Psychopharmacology|February 4, 2014
Comparison of the effects of Sertindole and Olanzapine on Cognition (SEROLA): a double-blind randomized 12-week study of patients diagnosed with schizophreniaRené Ernst Nielsen, Florence Odur, Torben Ostergaard, et al.Therapeutic Advances in Psychopharmacology|March 4, 2017
Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unitSiobhan H Gee, David M Taylor, Sukhwinder S Shergill, et al.Therapeutic Advances in Psychopharmacology|March 20, 2019
Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniquesMichael Ott, Julie K Mannchen, Fariba Jamshidi, et al.Therapeutic Advances in Psychopharmacology|April 9, 2019
Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidanceEmma Tay, Andreas Sotiriou, Garry G Graham, et al.Therapeutic Advances in Psychopharmacology|January 20, 2017
Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in NigeriaNosa Godwin Igbinomwanhia, Sunday Osasu Olotu, Bawo Onesirosan JamesPageof 55